TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER p: HAZARDOUS AND POISONOUS SUBSTANCES
PART 840 HEALTH AND HAZARDOUS SUBSTANCES REGISTRY CODE
SECTION 840.200 ADVERSE PREGNANCY OUTCOME


 

Section 840.200  Adverse Pregnancy Outcome

 

An adverse pregnancy outcome for an infant consists of one or more of the following case criterion:

 

a)         A diagnosis of a birth defect, made prenatally or by two years of age;

 

b)         A gestational age of less than 31 completed weeks (ICD-10-CM P07.21-P07.33);

 

c)         A diagnosis of fetal alcohol syndrome (ICD-10-CM Q86.0);

 

d)         A fetal or neonatal death;

 

e)         Substance Use

 

1)         Prenatal maternal, post-natal infant or post-natal maternal positive toxicology for any controlled substance (except drugs administered during labor and delivery);

 

2)         a maternal admission to illicit drug use, or cannabis use during the pregnancy that led to the delivery of this infant; or

 

3)         signs of drug toxicity or withdrawal; or

 

f)         A diagnosis of one of the following conditions made prior to discharge from the newborn hospitalization:

 

1)         Serious infections:

 

A)        Prenatal exposure to syphilis (ICD-10-CM Z20.2) or a diagnosis of congenital syphilis (ICD-10-CM A50.01-A53.9);

 

B)        Prenatal exposure to hepatitis B or hepatitis C  (ICD-10-CM Z20.2) or a diagnosis of hepatitis B or hepatitis C (ICD-10-CM P35.3);

 

C)        Prenatal exposure to chlamydia (ICD-10-CM Z20.2) or a diagnosis of a chlamydial infection ICD-10-CM A74.89, A74.9, or P23.1);

 

D)        Prenatal exposure to herpes (ICD-10-CM Z20.2) or a diagnosis of congenital herpes (ICD-10-CM P35.2);

 

E)        Group B streptococcus (ICD-10-CM J15.3 or P36.0);

 

F)         Gonococcal conjunctivitis (neonatorum) (ICD-10-CM P39.1);

 

G)        Congenital listeriosis (ICD-10-CM P37.2);

 

H)        Congenital rubella (ICD-10-CM P35.0);

 

I)         Congenital cytomegalovirus (ICD-10-CM P35.1);

 

J)         Tetanus neonatorum (ICD-10-CM A33);

 

K)        Septicemia of the newborn ICD-10-CM P36.0-P36.9);

 

L)        Prenatal exposure to human immunodeficiency virus (ICD-10-CM Z20.6); or

 

M)       Other congenital infections (ICD-10-CM P35.8, P35.9 or P37.0-P37.9).

 

2)         Endocrine, metabolic or immune disorder:

 

A)        Hypothyroidism (ICD-10-CM E03.0-E03.9);

 

B)        Adrenogenital syndrome (ICD-10-CM E25.0-E25.9);

 

C)        Inborn errors of metabolism (- ICD-10-CM E70.0-E79.9);

 

D)        Cystic fibrosis (ICD-10-CM E84.0-E84.9); or

 

E)        Immune deficiency disorder (ICD-10-CM D80.0-D81.9).

 

3)         Blood disorder:

 

A)        Leukemia (ICD-10-CM C91.0-C95.92);

 

B)        Hereditary hemolytic anemias (ICD-10-CM D58.0-D58.9);

 

C)        Constitutional aplastic anemia (ICD-10-CM D61.0-D61.09); or

 

D)        Coagulation defects (ICD-10-CM D65-D68.9).

 

4)         Other conditions:

 

A)        Neurofibromatosis (ICD-10-CM Q85.0-Q85.9);

 

B)        Cerebral lipidoses ICD-10-CM E75.4);

 

C)        Retinopathy of prematurity (ICD-10-CM H35.1-H35.17);

 

D)        Chorioretinitis (ICD-10-CM H30.00-H30.93);

 

E)        Strabismus (ICD-10-CM H50.00-H50.9);

 

F)         Endocardial fibroelastosis (ICD-10-CM I42.4);

 

G)        Occlusion of cerebral arteries (ICD-10-CM I63.30-I63.59 or I66.0-I66.9);

 

H)        Bronchopulmonary dysplasia (ICD-10-CM P27.1);

 

I)        Intrauterine growth retardation ICD-10-CM P05.0-P05.9);

 

J)         Intraventricular hemorrhage grade III (ICD-10-CM P52.21);

 

K)        Intraventricular hemorrhage grade IV ICD-10-CM P52.22);

 

L)        Seizures (ICD-10-CM P90);

 

M)        Other conditions leading to more than 72 hours on a ventilator (ICD-10-CM Z99.11);

 

N)        Conditions leading to extracorporeal membrane oxygenation (ECMO) (ICD-10-CM Z92.81)

 

O)        Erb's Palsy (ICD-10-CM P14.0)

 

P)         Hypoxic ischemic encephalopathy leading to cooling treatment (ICD-10-CM P91.63)

 

AGENCY NOTE:  The products of induced abortions shall not be reported to APORS. 

 

(Source:  Amended at 46 Ill. Reg. 2971, effective February 1, 2022)